Consent2Randomize is a privately held clinical research support organization that works directly with clinical research sites to assist with patient identification, prescreening, and enrollment workflows during active studies.

The organization was created to help research teams manage the increasing operational demands of enrollment while maintaining ethical standards, regulatory compliance, and full site control over consent and study conduct. Consent2Randomize does not replace site staff or clinical decision making and does not assume authority over consent or enrollment determinations.

Engagements are typically initiated when research sites are actively enrolling and identify a need for additional support identifying and prescreening potential participants. All workflows are designed to align with site specific protocols, institutional policies, and study requirements.

Consent2Randomize focuses on supporting patients through clear communication and thoughtful guidance, while helping research teams streamline prescreening processes in a way that is efficient, responsible, and respectful of participant choice. Patients are informed, participation is always voluntary, and research teams retain final oversight at every stage.

The organization operates with an emphasis on transparency, data privacy, and compliance, and works collaboratively with research teams to ensure that processes remain site controlled and aligned with ethical research practices.